​1. Market Overview and Growth Drivers​ The global ​ketoconazole market​ is experiencing robust growth, driven by rising fungal infections, expanding dermatological care, and innovative formulations. Valued at ​USD 1.2 billion in 2024, the market is projected to reach ​USD 1.8 billion by 2033, growing at a ​CAGR of 5.0%​​ . Key growth drivers include: ​2. Key Buyer Categories and Procurement Patterns​ ​2.1 Pharmaceutical Companies​ Major ​pharma buyers​ (e.g., Johnson & Johnson, Mylan, Teva) prioritize ketoconazole for oral and topical formulations. Recent trends include: ​2.2 Consumer Healthcare Brands​ Personal care giants (e.g., Unilever, L’Oréal) source ketoconazole for anti-dandruff shampoos. Key procurement drivers: ​2.3 Veterinary and Agricultural Buyers​ Ketoconazole is used in…